NCT04640623 2026-03-13SunRISe-1Janssen Research & Development, LLCPhase 2 Active not recruiting220 enrolled 1 FDA
NCT03022825 2025-10-16QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder CancerImmunityBio, Inc.Phase 2/3 Active not recruiting190 enrolled 1 FDA
NCT05243550 2024-11-04ENVISIONUroGen Pharma Ltd.Phase 3 Active not recruiting240 enrolled 20 charts 1 FDA